- AI-powered in-depth interviewing
- Sep 17, 2026
Evaluating and Expanding the Opportunity for a Rare Disease Asset
Our global pharma client had an asset that would improve the standard of care in a rare but chronic condition and wanted to understand the market landscape in key markets.